KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesDividends payablesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Zoetis (ZTS) Common Equity: 2011-2025

Historic Common Equity for Zoetis (ZTS) over the last 14 years, with Sep 2025 value amounting to $5.4 billion.

  • Zoetis' Common Equity rose 3.13% to $5.4 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $5.4 billion, marking a year-over-year increase of 3.13%. This contributed to the annual value of $4.8 billion for FY2024, which is 4.54% down from last year.
  • Per Zoetis' latest filing, its Common Equity stood at $5.4 billion for Q3 2025, which was up 8.46% from $5.0 billion recorded in Q2 2025.
  • Zoetis' 5-year Common Equity high stood at $5.4 billion for Q3 2025, and its period low was $4.1 billion during Q1 2021.
  • For the 3-year period, Zoetis' Common Equity averaged around $4.9 billion, with its median value being $5.0 billion (2025).
  • Its Common Equity has fluctuated over the past 5 years, first soared by 48.64% in 2021, then decreased by 7.97% in 2025.
  • Over the past 5 years, Zoetis' Common Equity (Quarterly) stood at $4.5 billion in 2021, then declined by 3.10% to $4.4 billion in 2022, then climbed by 13.49% to $5.0 billion in 2023, then declined by 4.54% to $4.8 billion in 2024, then climbed by 3.13% to $5.4 billion in 2025.
  • Its Common Equity was $5.4 billion in Q3 2025, compared to $5.0 billion in Q2 2025 and $4.7 billion in Q1 2025.